Icon

FOLOTYN (nda022468)- (20MG/ML (20MG/ML),40MG/2ML (20MG/ML))

PRALATREXATE ACROTECH BIOPHARMA
20MG/ML (20MG/ML),40MG/2ML (20MG/ML)
Yes No
2025-May-31 2014-Sep-24
2016-Sep-24 None
None No
FOLOTYN is a dihydrofolate reductase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
0 1 0
Total Other Developers 1
Drugs with Suitability No
20MG/ML (20MG/ML) ** ** - - -
40MG/2ML (20MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.